Association between Clinical Use of Colchicine and Risk of Type 2 Diabetes Mellitus among Gouty Patients: A Nationwide Cohort Study.

Chen-Chih Chu Yong-Chen Chen Ming-Hsun LinWen-Tung WuFeng-Cheng LiuHsiang-Cheng ChenYu-Ching Chou Chien-An Sun

Published in: International journal of environmental research and public health (2022)

This cohort study provides longitudinal evidence that the use of colchicine is associated with a reduced risk of T2DM. This conclusion, however, needs to be interpreted cautiously given the lack of body mass index data in the NHIRD. Further studies are needed to determine the clinical implications of this study.

Keyphrases

body mass index
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
electronic health record
type diabetes
big data
patient reported outcomes
metabolic syndrome
cross sectional
skeletal muscle
insulin resistance
deep learning
artificial intelligence
patient reported